For example, increase in serum levels of CCL2 is associated with progression from hepatic steatosis to NASH [63], and CCL2 expression is correlated with disease severity in Hepatitis C-dependent liver fibrosis [64]. The gene discussed is CCL2; the disease is Hepatic steatosis.